Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Furosemide in Indonesian Healthy Volunteers
NCT04982874Phase 1Completed
- Sponsor
- Kimia Farma
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of furosemide in edema and hypertension (HTN) (2 arms), sponsored by Kimia Farma. Primary endpoints: Geometric Mean Ratio of Maximum Concentration and Geometric Mean Ratio of Area Under Curve. Started Dec 2019; status: completed.
02
Drugs
furosemide
03
Conditions
edemahypertension (HTN)
Beyond the preview
Go deeper on NCT04982874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982874.